Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Quinidine Sulphate helps manage rare irregular heartbeat conditions
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
Time to combine innovation, access and technology to deliver positive patient outcomes
A pharma industry veteran with over three decades of experience in domestic as well as international markets
Flattish volume growth and subdued new launches were key factors for last month
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
Two out of three people under the age of 40 are at risk of prediabetes
Subscribe To Our Newsletter & Stay Updated
